ConductScience.org, home

Paper20160026

Celastrol suppresses angiogenesis-mediated tumor growth through inhibition of AKT/mammalian target of rapamycin pathway.

Pang X and 7 others. Cancer Res, 2010. Cited by 193 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Celastrol suppresses angiogenesis-mediated tumor growth through inhibition of AKT/mammalian target of rapamycin pathway. Papers, record 20160026. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/20160026

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Celastrol suppresses angiogenesis-mediated tumor growth through inhibition of AKT/mammalian target of rapamycin pathway.
PubMed
Journal
Cancer Res
PubMed
Year
2010
PubMed
Publication types
Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
193
iCite
Relative citation ratio, by iCite
5.26
iCite
Revised in PubMed
2025-05-29
PubMed

Authors8

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Pang XXiufeng
2Yi ZZhengfang
3Zhang JJing
4Lu BBinbin
5Sung BBokyung
6Qu WWeijing
7Aggarwal BBBharat B
8Liu MMingyao

Source PubMed

Download CSV of authors

Topics24

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Angiogenesis InhibitorsMajor topic
Intracellular Signaling Peptides and ProteinsMajor topic
Prostatic NeoplasmsMajor topic
Protein Serine-Threonine KinasesMajor topic
Proto-Oncogene Proteins c-aktMajor topic
TriterpenesMajor topic
Animals
Apoptosis
Cell Growth Processes
Cell Line, Tumor
Chemotaxis
Endothelial Cells
Humans
Male
Mice
Mice, Inbred BALB C
Mice, Nude
Neovascularization, Pathologic
Pentacyclic Triterpenes
Ribosomal Protein S6 Kinases, 70-kDa
Specific Pathogen-Free Organisms
TOR Serine-Threonine Kinases
Vascular Endothelial Growth Factor A
Xenograft Model Antitumor Assays

Source PubMed

Download CSV of topics

Grants6

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
CA-124787-01A2NCI NIH HHSUnited StatesPubMedPubMed
CA-16672NCI NIH HHSUnited StatesP01CA016672PubMed and NIHNIH RePORTER
P01 CA124787NCI NIH HHSUnited StatesP01CA124787PubMed and NIHNIH RePORTER
R01 CA106479NCI NIH HHSUnited StatesR01CA106479PubMed and NIHNIH RePORTER
1R01CA106479NCI NIH HHSUnited StatesR01CA106479PubMed and NIHNIH RePORTER
P30CA016672NIHNIH RePORTER

Download CSV of grants

Comments and corrections1

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn Papers
Erratum in30709873Correction: Celastrol Suppresses Angiogenesis-Mediated Tumor Growth through Inhibition of AKT/Mammalian Target of Rapamycin Pathway.https://conductscience.org/library/papers/30709873

Source PubMed

Download CSV of comments and corrections

References36

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
111669150A phase I study of ethyl acetate extract of the chinese antirheumatic herb Tripterygium wilfordii hook F in rheumatoid arthritis.J Rheumatol2001https://conductscience.org/library/papers/11669150PubMed
217110449Celastrol, a novel triterpene, potentiates TNF-induced apoptosis and suppresses invasion of tumor cells by inhibiting NF-kappaB-regulated gene products and TAK1-mediated NF-kappaB activation.Blood2007https://conductscience.org/library/papers/17110449PubMed
318829578Endothelial p70 S6 kinase 1 in regulating tumor angiogenesis.Cancer Res2008https://conductscience.org/library/papers/18829578PubMed
415840409Beneficial effect of tripterine on systemic lupus erythematosus induced by active chromatin in BALB/c mice.Eur J Pharmacol2005https://conductscience.org/library/papers/15840409PubMed
519075588mTOR pathway and mTOR inhibitors as agents for cancer therapy.Curr Cancer Drug Targets2008https://conductscience.org/library/papers/19075588PubMed
616322239Vascular endothelial growth factor contributes to prostate cancer-mediated osteoblastic activity.Cancer Res2005https://conductscience.org/library/papers/16322239PubMed
716169463The Akt-mTOR tango and its relevance to cancer.Cancer Cell2005https://conductscience.org/library/papers/16169463PubMed
819567671Acetyl-11-keto-beta-boswellic acid inhibits prostate tumor growth by suppressing vascular endothelial growth factor receptor 2-mediated angiogenesis.Cancer Res2009https://conductscience.org/library/papers/19567671PubMed
911513350Celastrol, a potent antioxidant and anti-inflammatory drug, as a possible treatment for Alzheimer's disease.Prog Neuropsychopharmacol Biol Psychiatry2001https://conductscience.org/library/papers/11513350PubMed
1019047305Oral mTOR inhibitor everolimus in patients with gemcitabine-refractory metastatic pancreatic cancer.J Clin Oncol2009https://conductscience.org/library/papers/19047305PubMed
1118653228Efficacy of everolimus in advanced renal cell carcinoma: a double-blind, randomised, placebo-controlled phase III trial.Lancet2008https://conductscience.org/library/papers/18653228PubMed
1215149849Role of the p70(S6K) pathway in regulating the actin cytoskeleton and cell migration.Exp Cell Res2004https://conductscience.org/library/papers/15149849PubMed
1317693255IKK beta suppression of TSC1 links inflammation and tumor angiogenesis via the mTOR pathway.Cell2007https://conductscience.org/library/papers/17693255PubMed
1416909005Celastrol blocks neuronal cell death and extends life in transgenic mouse model of amyotrophic lateral sclerosis.Neurodegener Dis2005https://conductscience.org/library/papers/16909005PubMed
1518339865Gambogic acid inhibits angiogenesis and prostate tumor growth by suppressing vascular endothelial growth factor receptor 2 signaling.Cancer Res2008https://conductscience.org/library/papers/18339865PubMed
1616984800Inhibition of NF-kappa B activation through targeting I kappa B kinase by celastrol, a quinone methide triterpenoid.Biochem Pharmacol2006https://conductscience.org/library/papers/16984800PubMed
1716651429Celastrol, a triterpene extracted from the Chinese "Thunder of God Vine," is a potent proteasome inhibitor and suppresses human prostate cancer growth in nude mice.Cancer Res2006https://conductscience.org/library/papers/16651429PubMed
1818177721The biology of cancer: metabolic reprogramming fuels cell growth and proliferation.Cell Metab2008https://conductscience.org/library/papers/18177721PubMed
1917803898Molecular understanding and modern application of traditional medicines: triumphs and trials.Cell2007https://conductscience.org/library/papers/17803898PubMed
2016769766Tripterine inhibits the expression of adhesion molecules in activated endothelial cells.J Leukoc Biol2006https://conductscience.org/library/papers/16769766PubMed

See all 36 referencesDownload CSV of references

Cited by101

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 193 citations.

PMIDTitleJournalYearIn PapersSource
42943713Celastrol and Its Derivatives in Breast, Ovarian, and Cervical Cancer: Molecular Targets, Signalling Networks, and Nanocarrier-Based Delivery.Molecules2026https://conductscience.org/library/papers/42943713PubMed
42366741Celastrol Suppresses Porcine Deltacoronavirus Replication by Modulating Endoplasmic Reticulum Stress-Associated Ca2+ Balance.Transbound Emerg Dis2026https://conductscience.org/library/papers/42366741PubMed
41257273Sirolimus and gastrointestinal angiodysplasia: Can an established agent change the way gastrointestinal bleeding is managed?World J Gastroenterol2025https://conductscience.org/library/papers/41257273PubMed
40480957Unveiling the Potential Binding Targets of Celastrol in Colorectal Cancer: A Proteomic Profiling Approach Integrating Cellular Thermal Shift Assay and Pulse Proteolysis.J Proteome Res2025https://conductscience.org/library/papers/40480957PubMed
39877708Advances in gastrointestinal vascular bleeding disorders: Successful sirolimus treatment in colonic angioectasia.World J Gastroenterol2025https://conductscience.org/library/papers/39877708PubMed
39494324Recent Trends in anti-tumor mechanisms and molecular targets of celastrol.Int J Biol Sci2024https://conductscience.org/library/papers/39494324PubMed
39456849Transcriptome and Metabolome Reveal Accumulation of Key Metabolites with Medicinal Properties of Phylloporia pulla.Int J Mol Sci2024https://conductscience.org/library/papers/39456849PubMed
38881873Celastrol alleviates diabetic vascular injury via Keap1/Nrf2-mediated anti-inflammation.Front Pharmacol2024https://conductscience.org/library/papers/38881873PubMed
38203539Withaferin A and Celastrol Overwhelm Proteostasis.Int J Mol Sci2023https://conductscience.org/library/papers/38203539PubMed
37110167Evolution of Natural Product Scaffolds as Potential Proteasome Inhibitors in Developing Cancer Therapeutics.Metabolites2023https://conductscience.org/library/papers/37110167PubMed
36967728The genome of Tripterygium wilfordii and characterization of the celastrol biosynthesis pathway.GigaByte2021https://conductscience.org/library/papers/36967728PubMed
36678677Targeting OPA1-Mediated Mitochondrial Fusion Contributed to Celastrol's Anti-Tumor Angiogenesis Effect.Pharmaceutics2022https://conductscience.org/library/papers/36678677PubMed
36567856Brevilin A Inhibits VEGF-Induced Angiogenesis through ROS-Dependent Mitochondrial Dysfunction.Oxid Med Cell Longev2022https://conductscience.org/library/papers/36567856PubMed
36367667Targeting PI3K/Akt signaling in prostate cancer therapy.J Cell Commun Signal2023https://conductscience.org/library/papers/36367667PubMed
36120370SHP2 inhibition improves celastrol-induced growth suppression of colorectal cancer.Front Pharmacol2022https://conductscience.org/library/papers/36120370PubMed
36017049Celastrol inhibits laser-induced choroidal neovascularization by decreasing VEGF induced proliferation and migration.Int J Ophthalmol2022https://conductscience.org/library/papers/36017049PubMed
35782744Celastrol inhibits the proliferation and migration of MCF-7 cells through the leptin-triggered PI3K/AKT pathway.Comput Struct Biotechnol J2022https://conductscience.org/library/papers/35782744PubMed
35695424Celastrol inhibits pathologic neovascularization in oxygen-induced retinopathy by targeting the miR-17-5p/HIF-1α/VEGF pathway.Cell Cycle2022https://conductscience.org/library/papers/35695424PubMed
35359864Celastrol Alleviates Autoimmune Hepatitis Through the PI3K/AKT Signaling Pathway Based on Network Pharmacology and Experiments.Front Pharmacol2022https://conductscience.org/library/papers/35359864PubMed
35273658Functional metabolome profiling may improve individual outcomes in colorectal cancer management implementing concepts of predictive, preventive, and personalized medical approach.EPMA J2022https://conductscience.org/library/papers/35273658PubMed

See all 101 cited byDownload CSV of cited by

Genes12

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/20160026

GET https://conductscience.org/api/papers/v1/20160026/references?page=2